PriceTargets.com logo

Vogenx - VOGX Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $48.50
  • Forecasted Upside: 233.79%
  • Number of Analysts: 3
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 1 Buy Ratings
  • 1 Strong Buy Ratings
$14.53 As of 10/16/2026 05:00 PM ET
▼ -1.52 (-9.47%)

This chart shows the closing price for VOGX by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Vogenx Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for VOGX and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for VOGX

Analyst Price Target is $48.50
▲ +233.79% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Vogenx in the last 3 months. The average price target is $48.50, with a high forecast of $55.00 and a low forecast of $42.00. The average price target represents a 233.79% upside from the last price of $14.53.

This chart shows the closing price for VOGX for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 3 contributing investment analysts is to buy stock in Vogenx. This rating changed within the last month from a Strong Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/23/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/22/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/20/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/18/2026
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/18/2026
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/17/2026
  • 1 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/15/2026
  • 1 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
10/15/2026

Latest Recommendations

  • 1 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
9/28/2026Zacks ResearchUpgradeHold
9/2/2026WBB SecuritiesInitiated CoverageSpeculative Buy$42.00
9/2/2026WBB SecuritiesInitiated CoverageSpeculative Buy$42.00
9/1/2026JonesTradingInitiated CoverageBuy$55.00
8/31/2026JonesTradingUpgradeStrong-Buy
(Data available from 10/16/2021 forward)

News Sentiment Rating

0.20 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/20/2026
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/19/2026
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/19/2026
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/18/2026
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/18/2026
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/17/2026
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/16/2026
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/16/2026

Current Sentiment

  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

  • No very positive mentions tracked during this time.
Vogenx logo
Vogenx Inc. is a clinical-stage biopharmaceutical company. It focused on the discovery and development of novel therapeutics for the treatment of serious diseases associated with dysfunctions in human metabolism, including PBH and gastroparesis. The company's product candidate includes mizagliflozin, is an orally administered, minimally absorbed small molecule drug candidate in development for the treatment of PBH, gastroparesis, and GIP-dependent Cushing's Syndrome. Vogenx Inc. is based in RALEIGH, NC.
Read More

Today's Range

Now: $14.53
Low: $14.25
High: $16.01

50 Day Range

MA: $25.06
Low: $13.00
High: $34.13

52 Week Range

Now: $14.53
Low: $12.95
High: $38.41

Volume

84,594 shs

Average Volume

131,551 shs

Market Capitalization

$215.77 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Vogenx?

The following equities research analysts have issued research reports on Vogenx in the last twelve months: JonesTrading, Wall Street Zen, WBB Securities, and Zacks Research.
View the latest analyst ratings for VOGX.

What is the current price target for Vogenx?

0 Wall Street analysts have set twelve-month price targets for Vogenx in the last year. Their average twelve-month price target is $48.50, suggesting a possible upside of 225.5%. JonesTrading has the highest price target set, predicting VOGX will reach $55.00 in the next twelve months. WBB Securities has the lowest price target set, forecasting a price of $42.00 for Vogenx in the next year.
View the latest price targets for VOGX.

What is the current consensus analyst rating for Vogenx?

Vogenx currently has 1 hold rating, 1 buy rating and 1 strong buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe VOGX will outperform the market and that investors should add to their positions of Vogenx.
View the latest ratings for VOGX.

How do I contact Vogenx's investor relations team?

Vogenx's physical mailing address is 3901 Barrett Drive, Suite 300, Raleigh, NC, 27609. The company's listed phone number is 919-659-5677 and its investor relations email address is [email protected]. The official website for Vogenx is vogenx.com. Learn More about contacing Vogenx investor relations.